18F-Fluselenamyl

DRUG2 trials

Sponsors

Washington University School of Medicine

Conditions

Alzheimer Disease

Unknown Phase

Fluselenamyl - Beta Amyloid PET Imaging for Alzheimer Disease

Active, not recruitingNCT05731440

Washington University School of MedicineAlzheimer Disease

Start: 2022-11-18End: 2027-12-01Target: 60Updated: 2026-06-09

Beta Amyloid PET Imaging for Alzheimer Disease With [18F]-Fluselenamyl

RecruitingNCT06439992

Washington University School of MedicineAlzheimer Disease

Start: 2023-11-07End: 2026-12-01Target: 60Updated: 2026-06-09